New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation

被引：0
|
作者：
Musso, M
Porretto, F
Crescimanno, A
Bondi, F
Polizzi, V
Scalone, R
Cajozzo, A
Mariani, G
机构：
[1] Univ Palermo, Cattedra Ematol TMO, I-90133 Palermo, Italy
[2] Univ Palermo, Div Ematol TMO, I-90133 Palermo, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
342
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Four years survival in autologous stem cell transplantation with moderate dose of idarubicin and busulphan as conditioning regimen in acute myelogenous leukemia
    Mashhadi, M. A., Sr.
    Ramzi, M.
    Alimoghaddam, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] The effectiveness of the conditioning regimen high dose melphalan with bortezomib with autologous transplantation of hematopoietic stem cells in patients with multiple myeloma
    Khorobrykh, Marina
    Zorina, Natalia
    Minaeva, Natalia
    Sherstnev, Philipp
    Paramonov, Igor
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 294
  • [43] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [44] Mitoxantrone and melphalan as conditioning regimen for autologous stem cell transplant for multiple myeloma.
    Beaven, Anne W.
    Comeau, Terrance
    Sharf, Andrew
    Moore, Dominic T.
    Serody, Jonathan
    Shea, Thomas C.
    Gabriel, Don A.
    BLOOD, 2006, 108 (11) : 834A - 834A
  • [45] High-dose idarubicin (I) and melphalan (M) with total body irradiation (TBI) or busulfan (Bu) as conditioning for allogeneic and autologous transplantation (SCT).
    Juliusson, G
    Malm, C
    Karlsson, K
    BONE MARROW TRANSPLANTATION, 1999, 23 : S74 - S74
  • [46] BTM: an alternative conditioning regimen for autologous stem cell transplantation
    De Rosa, G.
    Morelli, E.
    Montante, B.
    De Rosa, A.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
  • [47] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    Farnault, L.
    Venton, G.
    Pourroy, B.
    Jourde-Chiche, N.
    Ivanov, V.
    Arcani, R.
    Roche, P.
    Mercier, C.
    Colle, J.
    Fanciullino, R.
    Costello, R. T.
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1173 - 1175
  • [48] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [49] Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy
    Mallouri, Despina
    Sakellari, Ioanna
    Batsis, Ioannis
    Konstantinou, Varnavas
    Baliakas, Panayotis
    Antoniou, Athanasios
    Apostolou, Chrisa
    Anagnostopoulos, Achilles
    Fassas, Athanasios
    BLOOD, 2010, 116 (21) : 567 - 567
  • [50] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
12345